Invivo Therapeutics Holdings Corp Share Price OTC Bulletin Board
Equities
NVIV
US46186M1009
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
16/04 | North American Morning Briefing : Powell Comments, -2- | DJ |
02/04 | North American Morning Briefing : Stocks Seen -2- | DJ |
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.5M 376M |
---|---|---|---|---|---|
Net income 2021 | -9M -751M | Net income 2022 | -10M -835M | EV / Sales 2021 | - |
Net cash position 2021 | 17.72M 1.48B | Net cash position 2022 | 15.4M 1.29B | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.52
x | P/E ratio 2022 |
-0.34
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Toselli
CEO | Chief Executive Officer | 66 | 05/17/05 |
Director of Finance/CFO | 54 | 14/19/14 | |
Heather M. Hamel
LAW | General Counsel | - | 12/17/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 08/16/08 | |
Robert Rosenthal
BRD | Director/Board Member | 67 | 08/19/08 |
C. Merrifield
CHM | Chairman | 73 | 11/14/11 |
1st Jan change | Capi. | |
---|---|---|
+0.91% | 204B | |
+3.74% | 178B | |
+28.89% | 154B | |
+31.66% | 112B | |
+1.37% | 64.16B | |
+19.45% | 54.88B | |
-2.27% | 46.69B | |
-9.28% | 36.8B | |
-0.10% | 35.26B |
- Stock Market
- Equities
- NVIV Stock
- NVIV Stock